Cefditoren Pivoxil
Product Description
YUNGJIN PHARM. CO. LTD.
-
KR
-
2015On CPHI since
-
1Certificates
-
500 - 999Employees
Company types
Specifications
YUNGJIN PHARM. CO. LTD.
-
KR
-
2015On CPHI since
-
1Certificates
-
500 - 999Employees
Company types
More Products from YUNGJIN PHARM. CO. LTD. (84)
-
Product General APIs
Bepotastine Nicotinate Candesartan Cilexetil Febuxostat Loxoprofen Sodium Propacetamol HCl *Azilsartan / Azilsartan Kamedoxomil *Limaprost Alfadex *NMN (Nicotinamide Mononucleotide) *Pirfenidone *Taurolidine *Empagliflozin *Nintedanib Esylate
*Under development -
Product Candesartan Cilexetil API / Tab
Yungjin Pharma offers a range of products which includes candesartan cilexetil. Specification: JP. Description: White crystalline powder. Assay: 99.0 ~ 101.0 % (as anhydrous basis). Packaging: 5, 10, 25 kg, Fiber drum. Candesartan is an antihypertensive in the angiotensin II receptor antagonist class. Cont... -
Product Nintedanib API/Tab
Used for the treatment of idiopathic pulmonary fibrosis and along with other medications for some types of non-small-cell lung cancer -
Product Cefmetazole Sodium / Inj
cephamycin antibiotic, usually grouped with the second-generation cephalosporins -
Product Cefditoren pivoxil / Tab / Fine granule
An antibiotic used to treat infections caused by Gram-positive and Gram-negative bacteria that are resistant to other antibiotics. It is mainly used for treatment of community acquired pneumonia. It is taken by mouth and is in the cephalosporin family ... -
Product Baroscon Double action syspension
Relieve acidreflux, heartburn, indigestion, excuess stomach acid
-
Product Cefmetazole inj.
Yungjin Pharma offers a range of products which includes cefmetazole inj. Active ingredient: Cefmetazole sodium. Efficacy & Effects: Septicemia, respiratory infection, secondary infection in chronic respiratory disease, cholecystitis, cholangitis, urinary tract infection, intrauterine infection, adnexitis,... -
Product Cefmetazole Sodium
Yungjin Pharma offers a range of products which includes cefmetazole sodium. Specification: JP, KP, CP. Description: White to light yellowish white powder. Assay: 860 ~ 965 ?g/mg (as cefametazole and anhydrous basis). Packaging: 10 kg, Aluminium can. It is a 2nd generation Cephalosporin antibiotics. Inte... -
Product Cefotaxime inj.
Yungjin Pharma offers a range of products which includes cefotaxime inj. Active ingredient: Cefotaxime Sodium. Efficacy & Effects: Pneumonia, bronchitis, pyelonephritis, cystitis, urethritis, sepsis, bacterial endocarditis, osteomyelitis, peritonitis, gonorrhoea, intrauterine infection. Dosage: Adults: 1g~... -
Product Cefotiam Hexetil
Yungjin Pharma offers a range of products which includes cefotiam hexetil. Specification: JP. Description: White to light yellow powder. Assay: 615 ~ 690 ?g/mg (as cefotiam and anhydrous basis). Packaging: 25 kg, Fiber drum. Prodrug of 2nd generation cephalosporin administered intramuscularly or intravenou... -
Product Cefotiam Hydrochloride
Yungjin Pharma offers a range of products which includes cefotiam hydrochloride. Specification: JP, KP. Description: White to light yellow crystalline powder. Assay: 810 ~ 890 ?g/mg (as cefotiam and anhydrous basis). Packaging : 10 kg, Aluminium can. It is a 2nd generation Cephalosporin antibiotics. Inter... -
Product Cefotiam inj.
Yungjin Pharma offers a range of products which includes cefotiam inj. Active ingredient: Cefotiam hydrochloride. Efficacy & Effects: Infection in burn and operative wound, subcutaneous abscess, osteomyelitis, purulent, bronchitis, bronchiectasis, pneumonia, lung abscess, thoracic empyema cholecystitis, ch...
YUNGJIN PHARM. CO. LTD. resources (1)
-
Video OVERVIEW
"Improvement of world health advances through Globalization and Partnerships"
Company name : Yungjin Pharm. Co., Ltd
CEO : Chae Joon, Lee
Location : 13, Olympic-ro 35da-gil, Songpa-gu, Seoul, Korea
Foundation date : October 10, 1952
Representative products: Cephalosporin Antibiotic, Antipsychotic, Cardiovascular, Total Nutrition, and etc.
Yungjin Pharm. Co., Ltd was established in 1952, has been playing a major role as a forerunner in the Korean pharmaceutical industry for half a century. With our inspiring mission statement, "To relieve the suffering of mankind from diseases with our innovative, effective and safe pharmaceutical products", we have shown our
successful contribution not only within Korea, but also through global expansion. As a result, we have received a total of 25 awards including the President Award for Superior Product Development, the Prime Minister Award, Industry Award and many more. These accomplishments demonstrate our sustainability and commitment to the development of innovative products and business excellence in both overseas and domestic segments.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance